Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Harmony Biosciences Holdings (HRMY) Leases (2020 - 2025)

Historic Leases for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to $1.2 million.

  • Harmony Biosciences Holdings' Leases fell 4706.9% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 4706.9%. This contributed to the annual value of $2.1 million for FY2024, which is 947.1% down from last year.
  • Per Harmony Biosciences Holdings' latest filing, its Leases stood at $1.2 million for Q3 2025, which was down 4706.9% from $1.3 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' Leases' 5-year high stood at $3.3 million during Q4 2021, with a 5-year trough of $1.2 million in Q3 2025.
  • Moreover, its 5-year median value for Leases was $2.4 million (2023), whereas its average is $2.4 million.
  • As far as peak fluctuations go, Harmony Biosciences Holdings' Leases surged by 6843.72% in 2021, and later tumbled by 4908.29% in 2025.
  • Quarter analysis of 5 years shows Harmony Biosciences Holdings' Leases stood at $3.3 million in 2021, then decreased by 29.9% to $2.3 million in 2022, then rose by 1.38% to $2.3 million in 2023, then fell by 9.47% to $2.1 million in 2024, then tumbled by 42.13% to $1.2 million in 2025.
  • Its Leases was $1.2 million in Q3 2025, compared to $1.3 million in Q2 2025 and $1.7 million in Q1 2025.